Orchard Therapeutics Total Assets 2017-2021 | ORTX

Orchard Therapeutics total assets from 2017 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Orchard Therapeutics Annual Total Assets
(Millions of US $)
2020 $281
2019 $399
2018 $366
2017 $97
2016 $4
Orchard Therapeutics Quarterly Total Assets
(Millions of US $)
2021-09-30 $356
2021-06-30 $365
2021-03-31 $389
2020-12-31 $281
2020-09-30 $298
2020-06-30 $315
2020-03-31 $355
2019-12-31 $399
2019-09-30 $415
2019-06-30 $458
2019-03-31 $329
2018-12-31 $366
2018-09-30 $0
2018-06-30 $65
2018-03-31 $0
2017-12-31 $97
2016-12-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.171B $0.003B
Orchard Therapeutics plc is a biopharmaceutical company. It offers medical research, gene therapy and inherited disorder treatment services which transforms the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. Orchard Therapeutics plc is based in London, United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $121.281B 7.66
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.681B 21.48
Biohaven Pharmaceutical Holding (BHVN) United States $7.357B 0.00
Arcus Biosciences (RCUS) United States $3.170B 0.00
Emergent Biosolutions (EBS) United States $2.265B 8.14
Myovant Sciences (MYOV) United Kingdom $1.741B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.500B 0.00
Zymeworks (ZYME) Canada $0.902B 0.00
Ambrx Biopharma (AMAM) United States $0.391B 0.00
SQZ Biotechnologies (SQZ) United States $0.337B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.95